The global API intermediate market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). API intermediates are used as raw materials and are termed as compounds or agents that are used for the formulation of active pharmaceutical ingredients (API). Several technologies are used for the manufacturing of these intermediates such as amination, hydrogenation, alkoxylation, hydroformylation, electrochemistry, acetylene chemistry, phosgene chemistry, among others. The major factor for the growth of the market is the rising adoption of generic drugs coupled with the growing geriatric population.
According to the US Food & Drug Administration (FDA), in 2019, a total of more than 1,000 generic drugs were given tentative approvals and were finalized. This, in turn, is driving the demand for API intermediates for generic drugs manufacturing. Further, according to the Department of Economic and Social Affairs, there were 703 million people aged 65 years or over globally in 2019 which is anticipated to double to 1.5 billion in 2050. Greiatric population is prone to neurological disorders and chronic diseases, which in turn, is accelerating the demand for API intermediates in the manufacturing of drugs for the treatment of these conditions. However, stringent government regulations are hampering the growth of the global API intermediate market during the forecast period.
To Request a Sample of our Report on API intermediate Market: https://www.omrglobal.com/request-sample/api-intermediate-market
Some major players in the market include BASF SE, Sanofi S.A., and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2020, Sanofi announced the launch of a standalone company by combining Sanofi’s API commercial and development activities at six of its European production sites. The company stated that the spin-off company will be launched in 2022 with the name EUROAPI.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
- By Product
- By Type of Intermediate
- By Therapeutic Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-BASF SE, Sanofi S.A., and Pfizer Inc., among others.
A full Report of API intermediate Market is Available @: https://www.omrglobal.com/industry-reports/api-intermediate-market
Global API intermediate Market Report by Segment
By Product
- Chemical Intermediates
- Biotech Intermediates
By Type of Intermediate
- Patent Intermediates
- Non-patent Intermediates
By Therapeutic Application
- Oncology
- Diabetes
- Cardiovascular Disease
- CNS & Neurological Disorders
- Endocrinology
- Others
Global API intermediate Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
